Treatment of idiopathic west and lennox-gastaut syndromes by intravenous administration of human polyvalent immunoglobulins
- Cite this article as:
- van Rijckevorsel-Harmant, K., Delire, M. & Rucquoy-Ponsar, M. Eur Arch Psychiatr Neurol Sci (1986) 236: 119. doi:10.1007/BF00454021
- 29 Downloads
A total of 7 patients (3–21 years old) suffering from an intractable “primary” Lennox-Gastaut syndrome (LGS) were treated with i.v. high doses of polyvalent human immunoglobulins. Of these patients 6 improved following such treatment with a decrease in fits and an improvement in the EEG.
Hypotheses about the contribution of the treatment and immunopathological factors in some cases of idiopathic LGS are discussed.